These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15920131)
1. No cure, no pay. Møldrup C BMJ; 2005 May; 330(7502):1262-4. PubMed ID: 15920131 [TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical expenditure compared across countries. van Mosseveld C Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959 [TBL] [Abstract][Full Text] [Related]
3. [Medicoeconomic data on rare disease drugs: a move towards more transparency?]. Schwebig A; Duguet C; Ferry A; Bougé C; Fagon JY; Bismuth C; Ramon J Presse Med; 2012 May; 41 Suppl 1():S57-64. PubMed ID: 22487716 [No Abstract] [Full Text] [Related]
4. [Drug shortage--cause and prevention]. Madsen S; Claesson U; Wesenberg GR; Endresen M; Walter AB Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2154-5. PubMed ID: 23076482 [No Abstract] [Full Text] [Related]
5. Vendor competition, generic drugs spur drop in pharmaceutical prices. Seigner CA Mod Healthc; 1985 Oct; 15(21):56, 60-2. PubMed ID: 10317662 [No Abstract] [Full Text] [Related]
6. European prices of newly launched reimbursable pharmaceuticals--a pilot study. Martikainen J; Kivi I; Linnosmaa I Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136 [TBL] [Abstract][Full Text] [Related]
7. Prescription drug pricing: the consumer perspective. Searing A N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625 [No Abstract] [Full Text] [Related]
8. New rules for US drug reimbursement. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382 [No Abstract] [Full Text] [Related]
9. Face-off will new drugs pay off in time to counter patent losses for Forest Laboratories? Vukhac K; Rivkind I Fortune; 2012 Jun; 165(8):80. PubMed ID: 22741415 [No Abstract] [Full Text] [Related]
10. [Proposal on reviewing the overall healthcare expenditure and its allocation: focusing on medication expenses]. Takamuku M Nihon Geka Gakkai Zasshi; 2010 May; 111(3):189-94. PubMed ID: 20540336 [No Abstract] [Full Text] [Related]
11. Patient assistance and drug co-pay programs. Posit Aware; 2009; 20(2):26. PubMed ID: 19280744 [No Abstract] [Full Text] [Related]
12. Revised drug policy. Shelat AJ J Indian Med Assoc; 1995 Mar; 93(3):117-8. PubMed ID: 8522818 [No Abstract] [Full Text] [Related]
13. Drug industry is considering more use of differential pricing, conference hears. Sukkar E BMJ; 2011 Dec; 343():d8049. PubMed ID: 22155726 [No Abstract] [Full Text] [Related]
14. Deals landscape: notable deals in the pharmaceutical industry in the second quarter of 2008. Bright J; Lakeram M IDrugs; 2008 Aug; 11(8):584-91. PubMed ID: 18724496 [No Abstract] [Full Text] [Related]